Sun Pharma gains; Meda says no takeover talks

Reuters Market Eye - Shares in Sun Pharmaceutical Industries Ltd rise 2 percent after Swedish drugmaker Meda AB said it was not involved in discussions with a potential buyer, contradicting reports that the two companies were in talks.

(To read full story, click http://in.reuters.com/article/2013/06/05/meda-idINDEE95405420130605)

Two sources with direct knowledge of the situation had told Reuters on May 31 that Sun Pharmaceutical was in talks to buy Meda for $5 billion to $6 billion.

After those reports, investors had worried Sun would have to assume significant debt to finance the purchase.

(Reporting by Abhishek Vishnoi)